Tag: kidney safety
Chronic Kidney Disease and Metformin or SGLT2 Inhibitors: Dosing and Safety Guidelines 2026
Jan 7, 2026 / 12 Comments
Updated 2026 guidelines on metformin and SGLT2 inhibitor dosing for chronic kidney disease patients. Learn safe thresholds, monitoring protocols, and why combination therapy is now standard care.
READ MORERECENT POSTS
- How Generic Medications Save Thousands on Healthcare Costs
- How to Use Patient Advocacy Foundations for Medication Grants
- Single-Sided Deafness: CROS and Bone-Anchored Hearing Options Explained
- How to Interpret Risk vs. Benefit in FDA Safety Announcements
- Larch Arabinogalactan Supplements: Evidence‑Backed Benefits, Dosage, and Safety